Abstract: Deep polyp segmentation methods have shown remarkable potential in boosting diagnostic efficiency. Nevertheless, these methods rely on sufficient pixel-wise annotated data, which is ...

Credit: Getty Images Researchers evaluated adults with severe CRSwNP who had used tezepelumab to determine whether treatment effects continued after treatment ceased. Among patients with CRSwNP who ...

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

The cat was caught on camera using its most peculiar walk. It suspiciously lifted its front paws off the ground and stood on its hind legs for a moment. Not stopping there, it then dramatically arched ...

Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, according to a study published online Oct. 23 in JAMA Otolaryngology-Head & Neck Surgery. Richard G. Chiu, ...

TUESDAY, Oct. 28, 2025 (HealthDay News) -- The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic ...

The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...

Abstract: Colorectal cancer stands out as a major factor in cancer-related fatalities. The prevention of colorectal cancer may be aided by early polyp diagnosis. Colonoscopy is a widely used procedure ...

Findings showed treatment with tezepelumab significantly reduced the size of nasal polyps and nasal congestion compared with placebo. The Food and Drug Administration (FDA) has approved Tezspire ® ...